American Century Companies’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-81,734
Closed -$1.22M 2968
2026
Q1
$1.22M Sell
81,734
-12,166
-13% -$271K ﹤0.01% 2269
2025
Q4
$2.35M Buy
93,900
+34,905
+59% +$621K ﹤0.01% 2029
2025
Q3
$578K Buy
58,995
+46,239
+362% +$278K ﹤0.01% 2470
2025
Q2
$54.3K Buy
+12,756
New +$56.9K ﹤0.01% 2828
2025
Q1
Sell
-11,738
Closed -$68.4K 2930
2024
Q4
$68.4K Sell
11,738
-17,291
-60% -$173K ﹤0.01% 2860
2024
Q3
$347K Buy
29,029
+17,197
+145% +$220K ﹤0.01% 2590
2024
Q2
$128K Sell
11,832
-28,152
-70% -$305K ﹤0.01% 2789
2024
Q1
$453K Sell
39,984
-5,225
-12% -$67.4K ﹤0.01% 2480
2023
Q4
$634K Buy
45,209
+15,910
+54% +$214K ﹤0.01% 2276
2023
Q3
$362K Buy
29,299
+19,157
+189% +$195K ﹤0.01% 2387
2023
Q2
$91.6K Buy
+10,142
New +$61.2K ﹤0.01% 2694

Other funds holding OLMA

American Century Companies's OLMA Position: Q2 2026 in Review

American Century Companies sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 81,734 shares — an estimated $1.22M sold.

American Century Companies first reported a position in OLMA in Q2 2023 and held it in 11 quarters. The position peaked at $2.35M in Q4 2025. 167 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • American Century Companies reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 81,734 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
  • American Century Companies first reported a position in Olema Pharmaceuticals in Q2 2023 and held it in 11 quarters.
  • American Century Companies's Olema Pharmaceuticals position peaked at $2.35M in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.